Flexi® Tablet: Each film-coated tablet contains Aceclofenac BP 100 mg.
Flexi® SR Tablet: Each sustained release tablet contains Aceclofenac BP 200 mg.
Flexi® SR (Aceclofenac) is a non-steroidal agent with marked anti-inflammatory and analgesic properties. It is a potent inhibitor of the enzyme cyclooxygenase which is involved in the production of prostaglandins.
Pharmacokinetics: After oral administration, Aceclofenac is rapidly and completely absorbed as unchanged drug. Peak plasma concentrations are reached approximately 1.25 to 3.00 hours following ingestion. Aceclofenac penetrates into the synovial fluid, where the concentrations reach approximately 57% of those in plasma. The mean plasma elimination half-life is around 4 hours. Aceclofenac is highly protein-bound (≥99%). Aceclofenac circulates mainly as unchanged drug. 4-hydroxy aceclofenac is the main metabolite detected in plasma. Approximately two-thirds of the administered dose is excreted via the urine, mainly as hydroxymetabolites.
Pharmacodynamics: Aceclofenac has multi-factor mechanism of action. Outside the inflammatory cell, Aceclofenac is metabolized to 4'-hydroxyaceclofenac. The parent drug and the metabolite penetrate the inflammatory cells and then hydrolyzed to the active metabolites diclofenac and 4'-hydroxydiclofenac, which shabie 6, 1 and TNP released by the inflammatory cells and therefore suppress production of PGE2 at the site of inflammation. Aceclofenac prevents neutrophil adhesion and accumulation at the inflammatory site in the early phase and thus blocks the pro-inflammatory actions of neutrophils.
For the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
Flexi® Tablet:
Flexi® SR Tablet: The recommended dose is 200 mg, once-daily.
CONTRAINDICATION AND PRECAUTION:
Aceclofenac should not be administered to patients with active or suspected peptic ulcer or gastro-intestinal bleeding. It should not be given to patients with moderate to severe renal impairment. Close medical surveillance is also imperative in patients suffering from severe impairment of hepatic function. It should not be prescribed during pregnancy, unless there are compelling reasons for doing so. The lowest effective dosage should be used. Aceclofenac should not be administered to patients previously sensitive to Aceclofenac or in whom aspirin or NSAIDs precipitate attacks of asthma, acute rhinitis or urticaria or who are hypersensitive to these drugs.
The use of Aceclofenac should be avoided in pregnancy and lactation unless the potential benefits to the mother outweigh the possible risks to the fetus.
Keep at a cool and dry place, protected from light and moisture.
Flexi® Tablet: Each box contains 100 tablets in blister pack. Flexi® SR Tablet: Each box contains 30 tablets in blister pack.